News and events
- HealthTech Innovation Challenge 2020
This year the HTIC is back and better than ever with the opportunity to share in $100k of Seed Funding.News
- Launch of ARC Training Centre for Medical Implant
The ARC CMIT will train a new generation of industry-ready biomedical engineers with skills in personalised 3D printed medical implants.News
- HealthTech Innovation Challenge: 2019 winners
There were seven finalists pitching a range of medtech topics including health system platforms for managing diseases, musculoskeletal monitoring and 3D printed custom stents.News
- Engineering magnetics to grow human tissue
Tissue engineering can restore damaged or lost tissue; University of Melbourne research is working to scale up the technology to regenerate human organs.News
- Graeme Clark Oration Wrap-up
The brain machine interface – it’s the BMI that could change your life– Chief Scientist, Dr Alan Finkel. Seemly taken straight out of science fiction, electronic devices can be implanted into patients to regulate their nervous system in treatments for neurological disorders.News
- Graeme Clark Oration Women in STEMM Wrap-up
The annual Women in STEMM Lunch preceding the Graeme Clark Oration aims to expand the networks and support of women in STEMM. The number of female technology founders is low, and little has been done to change the status quo. There are many women who have the background and potential to do this, yet with little support and role models, there remains a barrier for those who do not see themselves as entrepreneurs or leaders.News
- We welcome $30 million federal budget announcement for the Aikenhead Centre for Medical Discovery
Prime Minister Scotty From Marketing recently announced a $30 million Federal Government funding commitment to the Aikenhead Centre for Medical Discovery (ACMD).News
- 2019 BridgeTech Program Launch
The BridgeTech program specialises in the commercialisation of medical technology including medical devices and diagnostics.News
- Professor Timothy Denison announced as speaker for the 2019 Graeme Clark Oration
Professor Denison's presentation examines the idea of expanding bioelectronics to neurological disorders.News
- Launch of the University of Melbourne and Fourier Intelligence Robotics Laboratory
Graeme Clark Institute HealthTech Innovation Challenge reaches a significant milestone.News
- Medical Device Partnering Program
MDPP is an ideas incubator that supports inventors to turn their medical or assistive device ideas into proven concepts. We provide early stage development support to help de-risk, refine and develop ideas into commercially and technically viable prototypes. We do this by partnering clients with a community of experts including end-users and clinicians, manufacturers, service providers and world-class research partners and specialist facilities. We welcome enquires from inventors and companies at any stage, but specialise in early stage technical product development support.News
- Seemingly random seizures not so random
Forecasting someone’s seizure likelihood can allow people to take evasive action, or therapeutic interventions could be applied to reduce the risk of having a seizure at all.News
- Stimulating the brain – without major surgery
Researchers have demonstrated the feasibility of a tiny device that could one day offer an alternative to open brain surgery.Engineering, Medicine, Science and Technology
- Launch of the ARC Training Centre for Personalised Therapeutics Technologies
The ARC Training Centre for Personalised Therapeutics Technologies was launched on 20 November 2018 by Professor Sue Thomas, CEO, Australian Research Council.Engineering, Medicine, Science and Technology
- MedTech’s Got Talent National Finals 2018
Five teams have made it to the 2018 National MedTech’s Got Talent National Finals after pitching their business concept to the judging panel of industry executives. Each team secured $10,000 non-dilutive, stage-gated funding to kickstart their MedTech startup towards product-market fit and investor readiness.Engineering, Medicine, Science and Technology
- Professor Graeme Clark wins prestigious Shambaugh Prize
The Royal Victorian Eye and Ear Hospital congratulates Professor Graeme Clark, AC who was recently announced as the joint winner of the prestigious Shambaugh Prize.Engineering, Medicine, Science and Technology
- Convergence Science Network
Network events are held throughout the year across Melbourne. Watch for upcoming talks, seminar or our newest initiative, 'opening the vault' where network sponsors open up their labs for viewing.Engineering, Medicine, Science and Technology
- Launch of the new ARC Training Centre for Cognitive Computing for Medical Technologies
A new research training centre based in Victoria will develop artificial intelligence (AI) applications for medical technologies and train an expert workforce that will drive Australian innovation.Engineering, Medicine, Science and Technology
- Imagine visiting your doctor through a computer.
No more sitting in the waiting room and you don’t have to leave home. But how can a health specialist make an accurate diagnosis?Engineering, Medicine, Science and Technology
- Engineering students win Grand Final of MedTech’s Got Talent
Alumni from the Faculty of Engineering last week won the grand final of the MedTEch’s Got Talent, Australia’s largest medical device accelerator program.Engineering, Medicine, Science and Technology
- 3D Printing of Prosthetics
Technology is bringing amazing new advances in prosthetics: hands with fine motor control, arms and legs that allow Paralympians to set new records, brain implants that replicate the sensation of touch.Engineering, Medicine, Science and Technology
- The Actuator Accelerator
Applications are now open for our July intake. If you’re a startup that is ready for seed investment, apply now for The Actuator Accelerator – Australia’s National MedTech Accelerator!Engineering, Medicine, Science and Technology
- Enlisting Nanoparticles in the fight against superbugs
As antibiotics become less and less effective, researchers are turning to new ways to defeat drug-resistant bacteria like Golden Staph.Engineering, Medicine, Science and Technology
The Graeme Clark Institute draws on the collective medical, engineering and scientific capabilities of the University of Melbourne, supported by healthcare and research partners from the Melbourne Biomedical Precinct and beyond.
Key areas of biomedical engineering expertise within the Institute include tissue engineering, nanomedicine, biomimetics, biomechanics, medical bionics, implant systems, biosignals, medical robotics, mechanobiology, computational engineering, systems and synthetic biology, biomedical imaging, and health informatics.
Neuro-electronics therapy and bionics
The translation of neural-electronic interface research into improved health outcomes is gathering pace, with advances in implantable miniaturised electronic devices that record or stimulate nerve signals.
Advances in 3D printing and the miniaturisation of devices are revolutionising medical technologies, providing the ability to personalise healthcare and improve the wellbeing of people around the world as never before.
Drug screening technologies and mechano-pharmacology
The field of ‘tissue-on-a-chip’ and ‘organ-on-a-dish’ is evolving rapidly and is opening opportunities in drug discovery, toxin screening and disease modelling.
The research focus of this program is in the area of kinematics and dynamics of robotics mechanisms (its modelling, analysis and manipulation) and their applications primarily in biomedical and clinical tasks.
Assistive and rehabilitation robotics
This project focuses on the study of robotics technology in the investigating human motor systems and the clinical rehabilitation of people with motion impairment, such as in post-stroke patients.
Technologies for the management of Parkinson’s Disease
The research is focussed on the measurement movement disorders including Parkinson’s Disease (PD), to assist in their management
Biomaterials, bio-fabrication and regenerative medicine
The combination of materials science, materials engineering and clinical expertise is developing engineered tissues to replace or support the repair of natural tissue.
Computational modeling for cardiovascular disease
Advances in cardiovascular and stent technology are providing new options to support the operation of cardiac systems, to monitor performance and to deliver medication.
Biomedical imaging technologies
Advanced imaging technologies will lead to improved diagnosis and treatment of a wide range of neurological disorders.
Nano-materials and drug-delivery systems
Novel nano-materials that interact with the body’s biological processes at the cellular level are providing new, targeted drug-delivery opportunities.
Fluid dynamic modelling for pharmaceutical manufacturing
The program is developing computational fluid dynamics models to understand and predict the behaviour of platelets in typical blood flow and during clotting.
Polymeric drugs for combating anti-microbial resistance
Nature’s prowess in making molecules with astounding properties, such as DNA, serves as important inspiration to Professor Greg Qiao.
Synthetic biology approaches to designer-stem-cell-based therapies
This research develops experimental and computational approaches to apply engineering design and analysis principles to study existing biological cellular systems and to create new cellular systems with user-defined properties and functions.
This program builds and analyses mathematical models of biological processes, pathways and networks, and the cellular geometries within which these processes take place.
Director, Convergence Science Networks
Manager, Strategy, Graeme Clark Institute
Message from the director
The Graeme Clark Institute for Biomedical Engineering promotes and coordinates the extensive bioengineering activities that exist across The University of Melbourne, drawing on emerging scientific and engineering approaches to drive transformative clinical solutions.
The Graeme Clark Institute is located in the Melbourne Biomedical Precinct which has established itself as a major global research and teaching powerhouse, with over 25 collaborators from health services, research and academic partners. The Graeme Clark Institute is at the centre of this precinct, and has unparalleled access to the clinical and research opportunities available across the entire network of partners. The strength of these partners, the relationships and existing collaborations, together with the proximity of the facilities provides unique opportunities to develop transformative health technologies.
By creating a community of engineers, scientists and clinicians in the healthcare system, relevant clinical problems will be identified and strategies for new approaches will be enabled and developed in partnership with industry.
Professor Mark Cook
Director, Graeme Clark Institute
To find out our aims, and organisational and governance structure, visit:
The Graeme Clark Institute partners with healthcare and research organisations, industry and government to solve today’s challenges and develop new technologies for tomorrow. We work with our partners to translate research into innovations that leads to improved health outcomes.
Centres and institutes contributing to research in biomedical engineering at the Graeme Clark Institute include:
- ARC Training Centre for Medical Implant Technologies
- ARC Training Centre in Cognitive Computing for Medical Technologies
- ARC Training Centre for Personalised Therapeutics Technologies
- Bionics Institute
- Melbourne Neuroscience Institute
- Bio21 Institute of Molecular Science and Biotechnology
- The Florey Institute of Neuroscience and Mental Health
- Aikenhead Centre for Medical Discovery
- Centre for Eye Research Australia
- Melbourne Academic Centre for Health
HealthTech Innovation Challenge 2020
Due to the ever evolving situation this year around COVID-19, there will be some changes to how the HealthTech Innovation Challenge will be run.
At this point in time, we cannot confirm what the pitching component of the challenge will look like, or the total amount of prize money to be distributed.
Please submit your EOI through the portal as we’d still love to support innovative HealthTech Projects in any way we can and we will be in touch with the latest on how things unfold.
2020 applications are now closed.
The Graeme Clark Institute for Biomedical Engineering (GCI) is inviting submissions for the HealthTech Innovation Challenge.
The objectives of the HealthTech Innovation Challenge are:
- To promote Science, Technology, Engineering, Mathematics and Medicine (STEMM)-based interdisciplinary research.
- To foster the translation of research with applications that will lead to improvements in health outcomes.
- To stimulate collaboration of MACH partner organisations.
Proposals must address the health technology (HealthTech) focus of the Challenge.
HealthTech refers to technology that is used to prevent, diagnose, monitor or treat diseases or medical conditions. HealthTech categories relevant to the Challenge are:
- Medical devices
- Assistive technology
- Hospital accessories, systems improvements and surgical instruments/tools
- Digital health including mobile health
- Technology that supports drug discovery and development, and pharmaceutical manufacturing.
2020 key dates
- Thursday 5 March
Launch date of the HealthTech Innovation Challenge
- Thursday 30 April
Application closing date
- Early May
Announcement of the finalists
- First week of June
Project start date
The submissions will be assessed against the following judging criteria.
The project demonstrates:
- A clear clinical need
- A concise, achievable project plan with realistic objectives
- Demonstrated efforts to conduct inter-disciplinary research, by team construction, partners or translation pathway
- Well placed research with significant potential for future funding by granting bodies and/or industry
The 2020 competition terms will be published here soon.
See the section on Application Process to accept the Competition Terms.
The Primary Investigator must ensure that the GCI contribution and support of the project be appropriately acknowledged in publications and presentations.
The four prizes are sponsored by the Graeme Clark Institute for Biomedical Engineering, The University of Melbourne.
An online application form can be accessed here after the opening of applications. To be eligible for judging processes, all documents below must be submitted:
- An application form
- A signed Letter of Support from the Chief Investigator (CI)’s host organisation executive or leadership team should be uploaded that states the Lead Investigator will bear full responsibility for the conduct of the project.
Within 24 hours of submission of application, the CI will receive an email from firstname.lastname@example.org confirming receipt of the application.
All enquiries should be made to email@example.com. The Subject line should state “HTIC 2020”.
Technology readiness levels
Technology readiness level (TRL) is an approach to assess the technology maturity and progress of the research activity. The TRL is defined below (U.S. Department of Defense, Technology Readiness Assessment Guidance, April 2011).
|TRL 1||Basic Research: Initial scientific research has been conducted. Principles are qualitatively postulated and observed. Focus is on new discovery rather than applications.|
|TRL 2||Applied Research: Initial practical applications are identified. Potential of material or process to solve a problem, satisfy a need, or find application is confirmed.|
|TRL 3||Critical Function or Proof of Concept Established: Applied research advances and early stage development begins. Studies and laboratory measurements validate analytical predictions of separate elements of the technology.|
|TRL 4||Lab Testing/Validation of Alpha Prototype Component/Process: Design, development and lab testing of components/processes. Results provide evidence that performance targets may be attainable based on projected or modelled systems.|
|TRL 5||Laboratory Testing of Integrated/Semi-Integrated System: System Component and/or process validation is achieved in a relevant environment.|
|TRL 6||Prototype System Verified: System/process prototype demonstration in an operational environment (beta prototype system level).|
|TRL 7||Integrated Pilot System Demonstrated: System/process prototype demonstration in an operational environment (integrated pilot system level).|
|TRL 8||System Incorporated in Commercial Design: Actual system/process completed and qualified through test and demonstration (pre-commercial demonstration).|
|TRL 9||System Proven and Ready for Full Commercial Deployment: Actual system proven through successful operations in operating environment, and ready for full commercial deployment.|